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We show that J~ forms of Neu differentiation factor 
(NDF), homologous to acetylcholine receptor-inducing 
activity, glial growth factor, and heregulin, prevent 
apoptotic death and stimulate DNA synthesis of the 
E14 Schwann cell precursor, an early cell in the rat 
Schwann cell lineage. When precursors are exposed 
to NDF in defined medium, they generate Schwann 
cells without the requirement for DNA synthesis and 
with a time course that is similar to that with which 
Schwann cells appear in embryonic nerves in vivo. 
Furthermore, a neuronal signal that also mediates pre- 
cursor survival and maturation is blocked by the extra- 
cellular domain of the ErbB4 NDF receptor, a protein 
that specifically blocks the action of NDFs. These ob- 
servations provide important evidence that NDF is one 
of the hitherto elusive neuron-gila signaling mole- 
cules long proposed to regulate development in the 
Schwann cell lineage. 
Introduction 
Glial growth factor (GGF) has been implicated in the regu- 
lation of Schwann cell development from its first descrip- 
tion as a mitogen for cultured rat Schwann cells (Raft et 
al., 1978; Marchionni et al., 1993). It has now emerged 
that GGF belongs to a novel growth factor group, the Neu 
differentiation factors (NDFs; Ben-Baruch and Yarden, 
1994) that have been cloned from rat (NDF; Wen et al., 
1992), human (heregulin; Holmes et al., 1992), bovine 
(GGF; Marchionni et al., 1993), and chick (acetylcholine 
receptor-inducing activity [ARIA]; Falls et al., 1993) tis- 
sues. They are encoded by a single gene but exist in an 
unusual variety of forms generated by alternative splicing. 
These forms fall into two major groups, designated ~ and 
I~, according to a difference in a crucial part of the mole- 
cule, an epidermal growth factor-like (EGF-like) domain 
that on its own appears sufficient for receptor activation 
(Wen et al., 1994). The NDF receptors are two related 
tyrosine kinases, HER-3/ErbB3 and HER-4/ErbB4 (Tzahar 
1These authors contributed equally to this work. 
et al., 1994; Wen et al., 1994). In addition, the ErbB2 pro- 
tein, which is expressed in Schwann cells, probably acts 
as an NDF coreceptor in combination with ErbB3 and 
ErbB4 (Cohen et al., 1992; Peles et al., 1993; Sliwkowski 
et al., 1994). In various celt types, activation of these recep- 
tors promotes proliferation or differentiation (Peles et al., 
1992; Falls et al., 1993; Goodearl et al., 1993; Pinkas- 
Kramarski et al., 1994; Vartanian et al., 1994). 
NDF may also be involved in the regulation of lineage 
choice in the rat neural crest (Shah et al., 1994). In these 
experiments, crest cell clones were grown in a cocktail of 
known and unknown growth factors to ensure that differen- 
tiated neurons and Schwann cells were readily generated 
over time in culture. Addition of NDF strongly and selec- 
tively suppressed the generation of neurons in a manner 
consistent with the idea that NDF acted on crest cells to 
make the choice of the neuronal lineage less likely and 
that of the Schwann cell lineage more likely. 
NDFs were the first polypeptide growth factors shown 
to control Schwann cell behavior in vitro (initially studied 
in this context as GGF extracted from brain), and they 
have remained prime candidate regulators of Schwann 
cell development ever since. Nevertheless, the only known 
effect of these proteins on cells in the Schwann cell lineage 
remains that originally described by Brockes et al. (1979), 
namely the stimulation of DNA synthesis in Schwann cells 
obtained from postnatal nerves. 
The idea that the embryonic period of nerve develop- 
ment might be a time when NDF has a particularly im- 
portant role to play in control of the Schwann cell lineage 
is supported by the cellular localization of NDF mRNA in 
rodent embryos during the second half of the gestation 
period (Marchionni et al., 1993; Orr-Urtreger et al., 1993; 
Meyer and Birchmeier, 1994). These studies have shown 
that the two main sources of axons in embryonic nerves, 
namely spinal motor neurons and dorsal root ganglion 
(DRG) neurons, are sites of strikingly high levels of NDF 
mRNA, whereas the glial cells within the nerve itself are 
negative. It is therefore pertinent to ask whether neu ronally 
derived NDF acts to regulate glial development during this 
period. Analysis of glial development in the limb nerves 
of rat embryos (Jessen et al., 1994; Gavrilovic et al., 1995) 
has now made it possible to address this question in some 
detail. 
In the rat hind limb, the embryonic period of nerve devel- 
opment spans about a week, from embryonic day 14 (E14), 
when a significant number of nerves are first present, to 
birth at E21. At birth, essentially all the glial cells isolated 
from peripheral nerves have the well-established pheno- 
type of Schwann cells, with some cells being in the initial 
stage of myelination (Jessen and Mirsky, 1992). It is, how- 
ever, only toward the end of the embryonic period, namely 
from E17 onward, that Schwann cells are present in large 
numbers in the major limb nerves. No such cells are pres- 
ent at the earliest stage of nerve development. Instead, 
at E14 essentially all the cells isolated from limb nerves 
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are Schwann cell precursors (Jessen et al., 1994). These 
cells represent a distinct intermediary stage in the genera- 
tion of Schwann cells from the neural crest. The precursors 
differ from Schwann cells in a number of ways: they die 
abruptly by apoptosis when removed from axonal contact 
in vitro; they do not express the Schwann cell marker $100 
in the cytoplasm; they are not induced to synthesize DNA 
by fibroblast growth factor 2 (FGF2) in the presence of 
forskolin, a typical Schwann cell mitogen combination; 
and in vitro they have a flattened morphology showing 
many cell-cell contacts. 
Thus, two separate members of the Schwann cell lin- 
eage figure in the embryonic development of major periph- 
eral nerves: Schwann cell precursors and Schwann cells. 
The time between E14/15 and E17/18 is critical in nerve 
development, since during this period Schwann cell pre- 
cursors progress to generate Schwann cells. Although this 
switch in glial phenotype involves change in a number of 
diverse cellular properties, it occurs relatively abruptly, 
so that only during a brief window at E16 can significant 
numbers of both cell types be isolated from the major limb 
nerves. In the present paper, we have asked whether NDF 
might be involved in regulation of survival, proliferation, 
and lineage progression of Schwann cell precursors, since 
these represent major issues in glial development during 
the embryonic period of nerve growth. 
The results show that NDF blocks death and, at higher 
concentrations, stimulates DNA synthesis in E14 precur- 
sors. Using multiple criteria todistinguish precursors from 
Schwann cells, we also show that, when exposed to NDF 
in defined medium, precursors generate Schwann cells in 
vitro with a time course similar to that with which Schwann 
cells appear in developing peripheral nerves in vivo. DNA 
synthesis is not necessary for this lineage progression to 
occur. NDF protein is not detected in E14 precursors but 
is present in the cell body and axons of E14 DRG neurons. 
Furthermore, we demonstrate that a neuron-derived signal 
that mediates precursor survival and maturation can be 
blocked by addition of the extracellular domain of the 
ErbB4 NDF receptor, a protein that specifically blocks the 
action of NDFs. These observations provide important evi- 
dence that NDF may be one of the hitherto elusive neuron- 
glia signaling molecules long proposed to regulate devel- 
opment in the Schwann cell lineage (Bray et al., 1981; 
Ratner et al., 1985; Jessen et al., 1987; Bunge et al., 1990; 
Jessen and Mirsky, 1992). 
Results 
NDF Rescues Schwann Cell Precursors in a 20 hr 
Survival Assay 
To test whether NDF could prevent the abrupt apoptotic 
death that precursors undergo in defined medium, precur- 
sors were exposed to various concentrations of NDF~-2 
and the corresponding ~ form, NDF~-2, in a 20 hr survival 
assay identical to that used previously (Jessen et al., 1994; 
Gavrilovic et al., 1995). These and all other experiments 
in this paper were carried out in entirely defined medium 
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Figure 1. I~ Forms of NDF Prevent Death of E14 Precursors 
(A) Results from a 20 hr survival ssay with survival percentage calcu- 
lated as described in Experimental Procedures. In this and all subse- 
quent graphs, each point represents the average _+ SEM. 
(B) Representative field of E14 cultures after 20 hr in defined medium 
only. 
(C and D) Representative field of E14 cultures after 20 hr in defined 
medium plus NDF~-2 (100 pM). (D) shows L1 immunofiuorescence 
view of (C). 
Magnification, 800 x. 
the medium contained a low insulin concentration (1 nM) 
that is sufficient o bind to insulin receptors without signifi- 
cant binding to type 1 insulin-like growth factor (IGF) recep- 
tors (Sara and Hall, 1990). It was found that NDFI~-2 acted 
as a potent, dose-dependent suppressor of precursor 
death, whereas the a form, which varies in the amino acid 
sequence of the EGF-like domain, had very little effect 
(Figure 1). 
Using identical conditions and assay, we investigated 
further which domains within the NDF molecule were re- 
sponsible for the survival effect. NDFI3-1 and NDFI~-3, 
forms that vary in the amino acid sequence of the carboxy- 
terminal tail, had effects very similar to those of NDFI3-2, 
whereas corresponding (~ forms were ineffective (data not 
shown). Survival was also obtained with a shorter form of 
NDFI3-1 (residues 177-246), which lacks both the immuno- 
globulin-like domain and the spacer domain of NDF (NDF- 
EGFI3-1 ; Figure 1), whereas the corresponding (~ form was 
essentially ineffective (data not shown). An isolated EGF- 
like domain of NDFI~ (residues 177-228), which also lacks 
the carboxy-terminal tail of NDF that in proNDF corre- 
sponds to the juxtamembrane region, was the most potent 
of all the forms tested (NDF-EGFI3; Figure 1). 
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Figure 2. NDF Stimulates DNA Synthesis in E14 Precursors 
The results how the percentage of Ll-positive cells that were also 
BrdU-positive following 1.5 hr long exposures to BrdU and double 
immunolabeling with antibodies to L1 and BrdU. The BrdU pulses 
were given to sister cultures at three different times during the first 
20 hr after plating. In (B) the medium was changed from one containing 
NDF6-2 to one containing FGF2 plus forskolin at 20 hr, and DNA 
synthesis was examined using two further 1.5 hr BrdU pulses as indi- 
cated. 
Thus, the EGF-like domain of NDFI3s is sufficient for 
essentially complete suppression of death in E14 Schwann 
cell precursors, whereas e forms of NDF support very low 
levels of survival under the conditions used in these experi- 
ments. 
NDF Stimulates DNA Synthesis in Schwann 
Cell Precursors 
In the experiments described above, survival often over- 
shot the 100 percentage mark at high NDF concentrations, 
suggesting that NDF could stimulate cell division. 
This was tested directly by monitoring DNA synthesis 
during the 20 hr survival period. DNA synthesis was de- 
tected using the bromedeoxyuridine (BrdU) method and 
double immunolabeling with antibodies against the cell 
adhesion molecule L1 to identify precursors. Sister cul- 
tures were exposed to three 1.5 hr pulses of BrdU with 
each pulse ending at 5, 15, or 20 hr after plating. The 
experiment was carried out in the presence of FGF2 plus 
forskolin, as a nonmitogenic ontrol (Gavrilovic et al., 
1995), or various concentrations of NDFI~-2 in medium 
containing 1 nM insulin and 13 nM IGF1 (Figure 2A). The 
5 hr pulse gave a sire liar proportion of BrdU-positive nuclei, 
irrespective of the NDF concentration used. This was ex- 
pected because the time lag generally involved in mito- 
genic responses ensures that DNA synthesis during the 
first few hours in vitro reflects the previous mitogenic input 
seen in vivo rather than the input from growth factors pres- 
ent in the culture dish. Furthermore, the percentage of 
precursors ynthesizing DNA at this point (120/0 - 14%) was 
in excellent agreement with the DNA synthesis rate of 
these cells in vivo, measured using BrdU pulses of similar 
duration (Stewart et al., 1993). In the subsequent period, 
DNA synthesis in cells exposed to FGF2 plus forskolin 
rapidly decelerated, in accordance with previous findings 
(Gavrilovic et al., 1995). However, NDFI3-2 acted as a 
dose-dependent mitogen: the mitogenic effect of 40 pM 
was barely detectable (although survival at this NDF con- 
centration was 100%; see Figure 3A); the initial rate of 
DNA synthesis was maintained in 120 pM; and it increased 
in 400 pM (Figure 2A). 
To confirm that NDF~-2 could also induce DNA synthe- 
sis in cells that had fallen out of division, precursors were 
maintained in FGF2 for 20 hr and then changed to a me- 
dium containing 400 pM NDFI3-2 (Figure 2B). This caused 
a rapid stimulation of DNA synthesis that, after 20 hr of 
exposure to N DF~-2, was similar in magnitude to that seen 
20 hr after plating using the same NDFI~-2 concentration 
(Figure 2A). Other forms of NDF~, including the isolated 
EGF-like domain alone, also stimulated DNA synthesis 
and showed sim liar dose-response relationships (data not 
shown). Comparison of the doses required to support sur- 
vival and stimulate DNA synthesis (Figure 2A; also see 
Figure 1) indicated, however, that rescue does not depend 
on stimulation of DNA synthesis, since low concentrations 
that are only weakly mitogenic nevertheless upport es- 
sentially full survival. This was confirmed in subsequent 
experiments (see below). 
NDFI3s therefore act both to block death and stimulate 
DNA synthesis in E14 Schwann cell precursors, in contrast 
to FGFs, which promote survival only. 
The Involvement of IGF1 in NDF-Driven Survival 
and DNA Synthesis 
Previously, we have shown that FGF-mediated rescue of 
precursors depends on the presence of high concentra- 
tions of insulin or IGF1 (1 ~M [5.7 ~g/ml] and 6.5-13 nM 
[50-100 ng/ml], respectively), indicating that FGF rescue 
depends on activation of type 1 IGF receptors (Gavrilovic 
et al., 1995). The present experiments howed, however, 
that NDFI~s could completely prevent precursor death in 
medium containing low insulin (1 nM) and no IGF1 (see 
above). 
To investigate this issue further, dose-response curves 
for NDFl~-2-mediated survival were generated under three 
different conditions: in the absence of insulin and iGF1; 
in the presence of 1 nM insulin only, to activate insulin 
receptors; and in the presence of 1 nM insulin plus 13 nM 
IGF1, to activate type 1 IGF receptors also (Figure 3A). 
Even in the absence of both insulin and IGF1, NDFI3-2 
was capable of complete rescue at 20 hr. In the presence 
of low insulin, NDF~-2 was more potent, the EDs0 (the con- 
centrations giving half-maximal survival) having shifted to- 
ward lower concentration by about 5- to 6-fold. Addition 
of IGF1 on top of low insulin promoted survival at the lowest 
NDFI3-2 concentrations only, leaving the EDs0 essentially 
unchanged. 
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Figure 3. The Effect of Insulin Growth Factors on NDF-Mediated Sur- 
vival and DNA Synthesis 
(A and B) Results from a 20 hr survival assay (see legend to Figure 1). 
(C) NDF stimulates DNA synthesis in the absence of type 1 IGF recep- 
tor stimulation. The results how the percentage of Ll-positive cells 
that were also BrdU-positive following exposure to various concentra- 
tions of NDFI3-2 in media with or without IGF1 as indicated. 
by low NDFI3-2 doses, we tested whether IGF1 would also 
enhance the very low survival generated by e forms of N DF 
(see Figure 1). Indeed, 13 nM IGF1 markedly enhanced 
NDFc~-2-mediated survival (Figure 3B). Under these condi- 
tions survival of about 60% could be obtained, albeit at 
high concentrations of NDF~-2. NDF~-I and NDFct-3 sup- 
ported survival comparable to that seen with NDF~-2 in 
the presence of 13 nM IGF1 (data not shown). 
As a test of the involvement of type 1 IGF receptor in 
NDF-regulated DNA synthesis, dose-response curves for 
NDFI3-2-stimulated DNA synthesis were generated in the 
presence of 1 nM insulin only, and in the presence of 1 
nM insulin plus 13 nM IGF1 (Figure 3C). DNA synthesis 
was monitored with the BrdU method and anti-L1 antibod- 
ies as before, except that the cells were exposed to only 
a single 1.5 hr BrdU pulse at 20 hr (equivalent to the last 
pulse in the three time point assay used previously). This 
showed that NDFI3-2 readily stimulated DNA synthesis in 
the presence of low insulin concentration (1 nM) without 
IGFI. Furthermore, although addition of IGF1 enhanced 
the mitogenic response, this effect was barely significant 
statistically. In one experiment, DNA synthesis in re- 
sponse to 400 pM NDF~-2 was measured in a similar way 
in the presence of 13 nM IGFI. Less than 1% of precursors 
were BrdU positive in this experiment. 
Together, these results indicate that high concentra- 
tions of insulin or IGF1 (and therefore presumably type 1 
IGF receptor stimulation) play a smaller role in NDF~- 
regulated survival and DNA synthesis in Schwann cell pre- 
cursors than might have been expected from previous 
studies on FGFs and other growth factors on cells in this 
lineage. 
NDF, but Not FGF2, Supports Long-Term 
Survival of Precursors 
Previously, two conditions have been shown to support 
the survival of Schwann cell precursors for more than 20 
hr: FGF2 in the presence of high concentrations of insulin 
plus a low amount of serum and, alternatively, defined 
medium conditioned by neurons (Jessen et al., 1994; Ga- 
vrilovic et al., 1995). Both situations involve exposure to 
unidentified factors, and so far, defined conditions that 
allow the survival of cells removed from E14 nerves for 
longer periods have not been identified. 
We therefore examined whether NDF~-2 could support 
longer-term precursor survival and compared it with FGF2. 
Both factors were applied in defined medium containing 
1 nM insulin and 13 nM IGF1. Survival was assessed as 
before, except that in addition to a 20 hr survival period, 
some coverslips were maintained for 44 and 68 hr prior 
to immunostaining with anti-L1 antibodies and counting 
(Figure 4A). In NDF, cell number at the end of the 3 day 
period was somewhat higher than at 3 h r, whereas in FG F2 
cell number fell rapidly after the first day. Using 1.5 hr BrdU 
pulses at the end of the first and second day in NDF]3-2, 
we found BrdU incorporation in Ll-positive precursors of 
3.0% and 3.8%, respectively. Thus, NDFI3-2 at 32 pM sup- 
ports the survival of Schwann cell precursors for several 
days, generating some increase in cell number toward the 
end of the period, owing to a low level of DNA synthesis. 
In FGF2, however, the cells died rapidly after the first day. 
Although E14 precursors after 20 hr in FGF2 could not 
at this point be rescued by FGF2, we found that they could 
be rescued completely by NDF. This was shown in experi- 
ments in which E14 precursors were maintained in FGF2 
for 20 hr and then changed to fresh FGF2 or to medium 
containing NDFI3-2: essentially all the cells changed from 
FGF2 to NDF survived the next 2 days, whereas most of 
the cells that remained in FGF2 medium died during the 
same period (Figure 4B). This shows that, after a 20 hr 
exposure to FGF2, precursors are not irreversibly set on 
a death course but have selectively lost responsiveness 
to FGF2. 
In the Presence of NDF, Precursors Generate 
Schwann Cells on Schedule and in 
the Absence of DNA Synthesis 
Having shown that NDF~-2 supported full survival of the 
Ll-positive (or nerve growth factor receptor [NGFR]-posi- 
tive) cells, obtained as Schwann cell precursors from E14 
nerves, for at least 4 days, we asked whether the develop- 
mental status of these cells changed during the culture 
period. If NDFI3-2, applied under the defined conditions 
used here, mimicked the conditions prevailing during ern- 
bryonic nerve development in vivo, essentially all the pre- 
cursors would convert to cells with the Schwann cell phe- 
notype during a 4 clay period (E14 + 4 = E18), since, in 
vivo, cells in E14/15 nerves have the precursor phenotype, 
whereas cells in E17/18 nerves have a Schwann cell phe- 
notype (Jessen et al., 1994; Gavrilovic et al., 1995). Alter- 
natively, it was possible that NDFI3-2 blocked apoptosis 
in E14 cells without providing the conditions required for 
NDF and Schwann Cell Precursors 
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Figure 4. Long-Term Survival of E14 Precursors 
(A) NDF (hatched bars) supports long-term survival, whereas the effect 
of FGF2 (closed bars) is transient. Survival was measured (see legend 
to Figure 1) in sister cultures at different times after plating and in the 
presence of NDF (32 pM) or FGF2 (180 pM, a supramaximal concentra- 
tion in a 20 hr assay). 
(B) NDF (hatched bars), but not FGF2 (closed bars), rescues precur- 
sors following a 1 day exposure to FGF2. All cultures were exposed 
to FGF2 (180 pM) for 1 day. Some cultures were then fixed and used 
for survival assessment (column at 20 hr), while other cultures were 
changed to fresh medium containing FGF2 or NDF~-2 (32 pM) as 
indicated. The survival of these cultures was measured after a further 
1 day (columns at 44 hr) or 2 days (columns at 68 hr). Survival was 
measured as before (see legend to Figure 1). 
lineage progression and Schwann cell generation. In cul- 
tures that initially consist of precursors only, Schwann cell 
generation can be monitored quantitatively by examining 
the gradual appearance of cells that express cytoplasmic 
$100 and survive in defined medium in vitro when plated 
at moderate cell density. Furthermore, E14 precursors, 
unlike neonatal Schwann cells, do not synthesize DNA in 
response to the combination of FGF2 and forskolin (see 
above). This suggested an additional feature differentiat- 
ing the precursor and Schwann cell phenotypes. In the 
following experiments, we first confirmed this by showing 
that a mitogenic response to FGF2 plus forskolin appears 
in vivo between E15 and E17. We then used the three 
criteria of cytoplasmic $100 expression, survival ability 
and mitogenic response to FGF2 and forskolin, to monitor 
the generation of Schwann cells from precursors in vitro. 
The Developmental Appearance of a Mitogenic 
Response to FGF2 
To determine when cells freshly isolated from embryonic 
nerves started to respond to FGF2 by DNA synthesis, cell 
cultures were prepared from E 14, E15, E17, E 18, and new- 
born nerves and maintained in FGF2 plus forskolin. During 
the first 20 hr after plating, DNA synthesis was measured 
using the three time point BrdU assay carried out pre- 
viously for E14 cells only (Figure 5A). This showed that 
at 5 hr DNA synthesis was considerably greater in E17 
and E18 cells than in E14, E15, or newborn nerves, re- 
flecting the peak of DNA synthesis seen during normal 
nerve development in vivo (Stewart et al., 1993). Also, 
in the presence of FGF2 and forskolin, DNA synthesis 
decelerated rapidly in the cell population from E14 and 
E15 nerves. The same result was obtained when the FGF2 
concentration was increased from 180 pM, which has 
supramaximal effects on DNA synthesis in neonatal 
Schwann cells, to 600 pM (data not shown). In contrast, 
the considerable initial synthesis level was maintained in 
E17 cells and elevated in E18 cells. As expected, the three 
time point assay also revealed a stimulation of DNA syn- 
thesis by FGF2 and forskolin in newborn cells. The sim- 
plest interpretation of these results is that FGF2 plus for- 
skolin in the medium used here stimulates DNA synthesis 
in Schwann cells but not in Schwann cell precursors. The 
mitogenic response to these factors can therefore be used, 
together with previously defined criteria, to monitor differ- 
entiation in the Schwann cell lineage and to examine the 
generation of Schwann cells from precursors. 
The Generation of Schwann Cells from E14 
Precursors in Vitro 
Cells were prepared from E14, E15, E17, E18, and new- 
born nerves and maintained in NDFI3-2 in defined medium. 
After 1-4 days in vitro their phenotype was assessed quan- 
titatively. For each assessment, the cells were removed 
from the culture dish, replated on coverslips, and exam- 
ined for ability to survive for 20 hr in defined medium only; 
cytoplasmic $100 immunoreactMty at 3 hr after plating; 
and DNA synthesis in response to FGF2 plus forskolin at 
5, 15, and 20 hr after plating. The replating strategy was 
used to eliminate the effects of growth factors bound to 
the culture substrate in the period prior to assessment, 
and the methods used to examine precursor versus 
Schwann cell phenotype were identical to those used pre- 
viously on cells freshly obtained from nerves at different 
ages. 
Initially, survival was measured in cells from E14, E15, 
E17, and newborn nerves after 1 day in vitro (Table 1). 
E14 + 1 ( = 15) day cells survived poorly, as did cells from 
E15 nerves, whereas E15 + 1 (= 16) day cells showed 
increased survival, in agreement with the increased sur- 
vival shown by cells removed from E16 nerves when com- 
pared with cells from E15 animals. The assay registered 
a much better survival of newborn cells after 1 day in vitro, 
in agreement with the observation that these cells survive 
well when tested directly after removal from the nerve. 
E17 + 1 (= 18) day cells showed survival similar to that 
of E18 cells. We then measured survival of E14 cells by 
replating after 2, 3, and 4 days in vitro (Table 1). E14 + 
2 (= 16) day cells survived significantly better than 
E14 + 1 ( = 15) day cells. A much larger increase in survival 
was, however, seen between E14 + 2 (= 16) day cells 
and E14 + 3 (= 17) day cells, and the survival of E14 + 
4 (= 18) day cells was somewhat higher than that seen 
with E14 + 3 day cells and comparable to that seen with 
newborn + 1 day cells. All of this is in line with the survival 
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Figure 5. A Mitogenic Response to FGF2 plus Forskolin Distinguishes Schwann Cells from Precursors 
(A) The results show the percentage of Ll-positive cells that also have BrdU-positive nuclei following three 1.5 hr long exposures to BrdU during 
the first 20 hr after plating of cells removed from animals at different developmental stages as indicated. All cultures were exposed to FGF2 (180 
pM) plus forskolin (5 p.M). 
(B) The results are from a three time point BrdU assay as described for (A). The assay was carried out during the first 20 hr after replating of cells 
that had been obtained from E14 animals and maintained for t, 3, and 4 days in NDFI3-2 (40 pM). 
Examinat ion of cytoplasmic  $100 immunoreact iv i ty  in 
this type of exper iment  revealed a comparab le  picture (Ta- 
ble 1). Few E14 + 1 (= 15) day  cells were $100 posit ive, 
whereas about  half of theE14+2(= 16) and E15+ 1 
(= 16) cells bound $100 ant ibodies.  The great  major i ty 
of E14 + 3 ( = 1 7) and E14 + 4 ( = 18) day  cells were $100 
posit ive. These  f igures are in good agreement  with those 
obta ined by immuno labe l ing  cells from nerves at equiva-  
lent ages. 
In a further test  of whether  E14 precursors  acquired the 
Tabte 1. Change in Survival Ability and $100 Expression during Precursor/Schwann Cell Conversion 
Cells (Age When Removed from Nerve Percentage of Cells That Express $100 Survival Percentage 
+ Days In Vitro) ± SEM 4- SEM 
E14+0 4 _ 3 1 ___ 2 
E15+0 4 4- 4 3 _+ 2 
E14+1 15 4- 2 12 4- 2 
E16+0 42 __+ 6 16 -.+- 5 
E14+2 41 _+ 4 30 -_+ 3 
E15+1 47 _+ 7 18 _+ 3 
E17+0 95 - 2 87 _+ 5 
E14+3 75 _+ 3 71 _+ 2 
E18+0 96 _+ 2 98 4- 2 
E14+4 84 _+ 3 85 _+ 9 
E17+1 93 4- 1 92 ___ 6 
Newborn + 0 93 4- 6 100 4- 4 
Newborn + 1 79 _+ 5 
Plus 0 days in vitro indicates experiments in which the survival assay was carried out immediately after removal of cells from nerves, and the 
survival percentages in these experiments and the percentage of cells expressing cytoplasmic $100 are obtained from Jessen et al., 1994. They 
are presented here to make direct comparison with the present results easy. Plus 1-4 days in vitro indicates experiments in which cells were 
maintained for 1-4 days in vitro prior to the survival assay (see Experimental Procedures). Each experiment was carried out using duplicate or 
triplicate coverslips, and each figure represents the average of three experiments, except for experiments with newborn cells, which were carried 
out twice. In this case, the figure represents standard deviation from a pooled total of 4 coverslips. 
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Schwann cell phenotype on schedule, DNA synthesis in 
response to FGF2 plus forskolin was examined in cells 
prepared from nerves at E14 and maintained in NDF for 
1-4 days (see Figure 5B). The phenotype of the cells was 
assessed during the first 20 hr following replating, using 
the three time point BrdU assay described previously. 
FGF2 plus forskolin was not mitogenic for E14 + 1 (= 15) 
day cells, although this combination stimulated DNA syn- 
thesis in E14 + 3 (= 17) day cells and in E14 + 4 (= 18) 
day cells. In other experiments, we showed that exposure 
to 5 I~M forskolin for 20 hr induced high levels of Po mRNA 
in precursors exposed to NDFI3-2 for 4 days and replated, 
as expected if these cells were Schwann cells (data not 
shown). 
Together, these observations how that, when cultures 
of E14 precursors are exposed to NDFI3-2 under defined 
conditions, the phenotype of the cell population changes 
gradually but comprehensively from that characterizing 
precursors to that of Schwann cells. This occurs with a 
time course similar to that of Schwann cell appearance 
in nerves during development in vivo. 
DNA Synthesis during Schwann Cell Generation 
When DNA synthesis was measured, using 1.5 hr BrdU 
pulses, during the 1-4 day culture periods that preceded 
th(; phenotypic assessment described in the previous sec- 
tion, it was found to range between 10% and 20%, which 
i~ comparable to the levels of DNA synthesis in vivo during 
the period of E14-E18 (Stewart et al., 1993). We now 
asked whether the gradual replacement of cells with the 
precursor phenotype by cells with the Schwann cell pheno- 
type in the cultures described above was dependent on 
this rate of cell division, or whether it could take place in 
cultures where DNA synthesis was insignificant. 
In these experiments we took advantage of the observa- 
tion that at low concentrations NDFI3-2 can support sub- 
stantial survival while inducing very little DNA synthesis 
(see above). Cells removed from E14 nerves were there- 
fore maintained in NDF~-2 at 28 pM for 4 days (E14 + 
4 = 18) prior to being assessed for precursor/Schwann 
cell phenotype on the bases of survival, $100 expression, 
and FGF2 responsiveness as described above. DNA 
synthesis measured only 1.t% _+ 0.4%, 1.9% _ 0.6%, 
and 1.9% _+ 0.8% on days 1,2, and 3 in vitro, respectively. 
When the phenotype of these cells was assessed on the 
fourth day, 67% _+ 8% of the Ll-positive cells survived 
for 20 hr in defined medium, 89% + 3% expressed cyto- 
plasmic $100, and DNA synthesis in the presence of FGF2 
plus forskolin increased from 3.0% to 13.2% during a 20 
hr period. Thus, about a 10-fold drop in DNA synthesis to 
very low levels did not materially alter the extent of 
Schwann cell generation. To investigate further the rela- 
tionship between DNA synthesis and Schwann cell gener- 
ation from precursor cells, E14 precursors were main- 
tained in NDF~-2 at 16 pM for 3 days in the continuous 
presence of BrdU in two separate experiments. The cells 
were then assayed for precursor/Schwann cell phenotype 
by measuring 20 hr survival as described above, except 
that at the end of the 20 hr period, we carried out double 
immunolabeling for BrdU and L1. This showed that 58% 
of the surviving Ll-positive cells (i.e., Schwann cells) had 
not incorporated BrdU during the 3 day period, whereas 
the relative number of cells that had acquired the Schwann 
cell phenotype in this low NDF~-2 concentration was un- 
changed from that seen at higher concentrations. 
These experiments make it very unlikely that the 
Schwann cells generated in these cultures arise from a 
hypothetical population of rapidly dividing stem cells, and 
they show that at least the great majority of these cells 
must have originated in E14 precursors that converted to 
Schwann cells without the requirement of cell division. 
Soluble ErbB4 Protein Blocks Survival Activity in 
Neuron-Conditioned Medium 
Previously, defined medium conditioned by purified cul- 
tures of DRG neurons was shown to contain proteinaceous 
survival agent(s) that suppressed apoptosis of precursors 
in a dose-dependent way and allowed E15 precursors to 
progress to Schwann cells during a period of 5 days with- 
out the requirement for cell division (Jessen et al., 1994). 
Since these effects are similar to those of NDF, we now 
asked whether this activity was NDF. This was done by 
testing whether the activity could be blocked by addition 
of a soluble hybrid protein containing the NDF binding site 
of the ErbB4 receptor. 
To ensure unambiguously that the activity in the condi- 
tioned medium was of neuronal origin, we used DRG neu- 
rons purified by immunopanning to yield cultures in which 
>95% of the cells were neurons at the time of medium 
collection (Figure 6A, upper panel). We confirmed immu- 
nocytochemically that the neurons in these cultures ex- 
pressed NDF protein (Figure 6A, lower panel). Defined 
medium without serum was conditioned by these cultures 
for 24 hr. Using the 20 hr survival assay described pre- 
viously and cells from E14 nerves, this medium was then 
tested alone or following addition of 1 or 3 l~g/ml ErbB4 
protein. Control experiments involved the addition of 
ErbB4 to survival medium containing FGF2 together with 
IGF1 and forskolin to test for nonspecific effects, and the 
addition of ErbB4 to survival medium containing recombi- 
nant NDF~-2 to verify that the receptor protein blocked 
the effects of NDF under the prevailing experimental con- 
ditions. ErbB4 had no effect on FGF-mediated survival of 
E14 cells but strongly inhibited the effect both of NDFI~-2 
and neuron-conditioned medium (Figure 6B). In other ex- 
periments, we found that the ErbB4 protein also caused 
a 65% reduction of precursor survival in a 20 hr survival 
assay of neuron-precursor cocultures. In this system, pre- 
cursors are seeded on top of extremely sparse cultures 
of pure neurons, and survival of precursors is mediated 
by contact with axons, in the absence of any detectable 
survival activity in the culture medium (Z. D. unpublished 
data). 
The ErbB4 receptor has not been found to bind to factors 
other than those of the N DF family. It is therefore very likely 
that the major active ingredient in the neuron-conditioned 
medium is NDF. ErbB4 exerted a stronger inhibitory effect 
on 40 pM NDFI~-2 than it did on the neuron-conditioned 
medium. This could be due to the concentration of NDF 
in the neuron-conditioned medium being higher than 40 
pM. Alternatively, the conditioned medium may contain 














0 1 3 
ErbB4 (p-g/ml) 
NDF~-2 FGF-2 
0 1 3 0 1 2 3 
ErbB4 (l~g/ml) ErbB4 (t~g/ml) 
Figure 6. The Neuron-Derived Precursor Survival Signal Is Likely to be NDF 
(A) The upper panel is a representative phase-contrast view showing the appearance of the highly purified, immunopanned DRG cultures used 
to generate conditioned medium. The photograph was taken 48 hr after plating; over 95% of the cells in these cultures were neurons (magnification, 
400 x ). The lower panel shows NDF immunoreactivity in a DRG culture, similar to the one shown in the upper panel. The cells were labeled using 
the 5D6A anti-NDF antibody. Note immunolabeling of neuronal cell bodies and bundles of naked neurites (magnification, 600 x ). 
(B) Soluble ErbB4 protein blocks the survival activity in DRG-conditioned medium and the survival effect of NDFIf,-2; the survival effect of FGF2 
is unaffected. The results are from 20 hr survival assays. 
(C) Immunotabeling of E14 DRG neurons and precursors using antibodies against NDF, ErbB4, and ErbB2, as indicated on the immunofluorescence 
micrographs in the upper panels. The lower panels show the corresponding phase-contrast views. Note that both celt bodies and processes of 
the two DRG neurons are NDF positive (antibody 5D6A), whereas E14 precursors are NDF negative. ErbB4 immunolabeling is uniform and 
present in essentially all precursors, whereas ErbB2 labeling varies more from cell to cell (controls were negative; see Experimental Procedures). 
Magnification, 700-800 x.  
other  neuron-der ived  factors  that synerg ize  with NDF to 
promote  precursor  survival.  
Localization of NDF and NDF Receptors 
in E14/15 Cells 
To local ize NDF protein in E14 DRG neurons,  we used 
ant i -NDF ant ibod ies  and immunoh is tochemica l  methods.  
When neurons  d issected f rom E14 an imals  were  exam-  
ined after  1 -2  days in vitro, strong immunolabe l ing  was  
seen in both the cell bod ies  and neurona l  p rocesses  (Fig- 
ure 6C). No s igni f icant  ant ibody binding was detected in 
E14 precursors  in similar immuno labe l ing  exper iments  
(Figure 6C). Comparab le  results were  obta ined using 
three di f ferent  ant i -NDF ant ibod ies  (see Exper imenta l  Pro- 
cedures).  
Express ion  of the ErbB4 NDF receptor  and of  the ErbB2 
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NDF coreceptor was also examined by immu nohistochem- 
istry; suitable antibodies against the rat ErbB3 receptor 
were not available (Figure 6C). Essentially all E14 pre- 
cursors showed speckled and apparently membrane- 
associated immunolabeling when examined with antibod- 
ies against ErbB4. The large majority of precursors also 
bound antibodies against ErbB2, but the intensity of the 
immunolabeling was more variable in this case. 
Discussion 
The present results show that 13 forms of NDF regulate 
survival and DNA synthesis of E14 Schwann cell precur- 
sors. NDF also supports orderly lineage progression of 
these cells since, in the presence of NDF, they form 
Schwann cells in vitro with a time course that is similar 
to that of Schwann cell appearance in major embryonic 
nerves in vivo. Under defined conditions in media without 
serum, no other growth factor is presently known to exert 
comparable ffects on these cells. A protein that regulates 
precursor development in a similar way was previously 
described in defined medium conditioned by DRG neurons 
(Jessen et al., 1994). Here we report that the effect of this 
protein is abolished by exposure to a soluble form of the 
extracellular domain of the ErbB4 NDF receptor, a protein 
that binds to NDF with a very high degree of specificity 
(Culouscou et al., 1993; Plowman et al., 1993a, 1993b; 
Tzahar et al., 1994). Together, these observations identify 
NDF as a neuron-glia signal that controls survival and 
differentiation of Schwann cell precursors in a simple and 
well-defined in vitro model of neuron-glia interactions dur- 
ing embryonic nerve development. NDF is likely to carry 
out a similar function in vivo, particularly in view of the 
strikingly high NDF mRNA expression in those neurons 
that form embryonic peripheral nerves (Marchionni et al., 
1993; Orr-Urtreger et al., 1993; Meyer and Birchmeier, 
1994) and in view of the present observation that these 
cells express NDF proteins in cell bodies and processes 
while Schwann cell precursors show low or no NDF ex- 
pression. 
Although the existence of neuronal signals responsible 
for driving differentiation i the Schwann cell lineage has 
been a central idea in studies on PNS development for a 
long time, these signals have remained unknown at the 
molecular level. The molecular identification of an im- 
portant component of these signals is therefore a signifi- 
cant step forward. 
NDF and the Suppression of Cell Death 
NDF potently and completely blocked the acute apoptotic 
death of E14 precursors. This effect was seen in com- 
pletely defined media using cells that had never been ex- 
posed to serum or other unidentified factors, and the res- 
cue required neither insulin nor IGFI. 
The effect of NDF differs from the survival effects of 
FGF2 described previously (Jessen et al., 1994; Gavrilovic 
et al., 1995) in at least two respects. First, NDF supports 
precursor survival for several days in defined medium with- 
out serum, whereas the effect of FGF2 turned out to be 
surprisingly transient under these conditions, lasting es- 
sentially for 1 day only. Evidently, longer-term survival in 
FGF2 depends on co-operativity between FGF2 and se- 
rum factors (Jessen et al., 1994). Second, NDF blocks 
death in medium containing a low concentration of insulin 
(10 nM) and no IGF1, i.e., in the apparent absence of 
type 1 IGF receptor stimulation (Sara and Hall, 1990). The 
action of FGF2, in contrast, crucially depends on a high 
concentration of IGFI. 
When a half-maximal concentration of NDF was used, 
in combination with low doses of insulin for activation of 
the insulin receptor only (I n M), the two factors synergized 
strongly in blocking cell death. However, even in the com- 
plete absence of both insulin and IGF1, higher concentra- 
tions of NDF supported survival similar to that seen in 
media containing low insulin or low insulin plus a high 
concentration of IGF1. Surprisingly, therefore, neither in- 
sulin receptor nor IGF receptor activation is necessary for 
NDF-mediated blockage of apoptosis in these cells. 
Regulation of DNA Synthesis Differs between 
Schwann Cells and Precursors 
In the present experiments, we have established an addi- 
tional phenotype that distinguishes E14/15 precursors 
from E17 and older Schwann cells, namely the absence 
or presence of a mitogenic response to FGF2. We found 
previously that the p75NOFR/L1-positive precursors in E14 
nerves do not respond to FGF2 plus forskolin by stimula- 
tion of DNA synthesis (Gavrilovic et al., 1995). These cells, 
which are dividing at an appreciable rate in the nerve 
(Stewart et al., 1993), fall out of division during the first 
20 hr in the culture dish, even in the presence of FGF2 
and forskolin, although these factors effectively block 
apoptosis during the same period. We show here that the 
same applies to precursors from E15 nerves, while the 
Ll-positive population from E17 nerves responds differ- 
ently. Over 80% of these cells are Schwann cells on the 
basis of survival ability and $100 expression. They are 
dividing rapidly in vivo (Stewart et al., 1993), and this rate 
is maintained in the presence of FGF2 plus forskolin during 
the first 20 hr in vitro. Without FGF2 and forskolin, these 
cells survive but fall out of division during the same period. 
Cells removed from E18 and newborn nerves also respond 
to FGF2 plus forskolin by stimulation of DNA synthesis. 
The molecular basis for this difference in FGF respon- 
siveness between E14/15 Schwann cell precursors on the 
one hand and E17 and older Schwann cells on the other 
now remains to be determined. 
Schwann Cell Generation 
$100 expression, survival requirements, and mitogenic 
response to FGF2 represent a diverse collection of appar- 
ently unrelated phenotypic features. Nevertheless, all 
three are subject to strong developmental regulation in 
the Schwann cell lineage. They change with a similar time 
course and during the same period of embryonic nerve 
development, i.e., between E14 and E18 with the major 
shift occurring between E15 and E17. This comprehensive 
phenotypic hange can now be reproduced under defined 
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condit ions in vitro: L l /NGFR-pos i t ive  precursors removed 
from E14 nerves and exposed to NDFI3-2 for 1-4 days 
show a gradual alteration in all three parameters  that fol- 
lows a t ime course very similar to that seen in vivo. This 
suggests the existence of a program in E14 cells for coordi- 
nating the expression of a substantial  number  of function- 
ally diverse genes. It is l ikely that this program is driven 
by NDF. Alternatively, it may unfold cell autonomously  in 
cells in which NDF has blocked apoptosis.  The resolution 
of these issues and the molecular  identif ication of the un- 
derlying gene regulatory mechan isms represent important 
future lines of work. 
Experimental Procedures 
Antibodies 
Rabbit antiserum to bovine $100 protein (Dakopatts A/C) was used 
at a dilution of 1:10,000. Monoclonal antibody (MAb) 192 IgG, which 
recognizes the low affinity p75 NG~R, was a gift from E. Johnson, Jr., 
and was used in the form of ascites fluid at a dilution of 1:100. MAb 
ASCS4, which in the rat recognizes the cell adhesion molecule L1 
(Sweadner, 1983), was a gift from Dr. A. Furley. It was used in the 
form of cell culture supernatant. MAb against BrdU was a gift from 
M. Jones and Dr. D. Mason and was used at a dilution of 1:100. Rabbit 
antiserum to recombinant rat NDF (Wen et al., 1994) was used at a 
concentration of 1:50. Affinity-purified rabbit antiserum 1915 to recom- 
binant human NDFwas made and characterized by Dr. D. Wen, Amgen 
Center, and was used at a concentration of 5-10 #g/ml. Mouse MAb 
5D6A against recombinant human NDF was made and characterized 
by Dr. D. Chang, Amgen Center, and was used at a dilution of 5-10 
~g/ml. MAb K-15 to ErbB2 receptors and MAb C-18 to ErbB4 receptors 
were from Santa Cruz Biotechnology (used at 1 ~g/ml). OX7 hybridoma 
cell line was from European Collection of Animal Cell Cultures. Rabbit 
anti-mouse immunoglobulin was from Dakopatts A/C. Goat anti-human 
antibody was from Sigma Chemical Company. Fluorescein conjugated 
to goat anti-rabbit immunoglobulin (Cappel Labs), absorbed with 
mouse immunoglobulin to remove cross-reacting antibodies, and tet- 
ramethyl rhodamine conjugated to goat anti-mouse immunoglobulin 
(Cappel Labs), absorbed with rabbit immunoglobulin to remove cross- 
reacting antibodies, were both used at a dilution of 1:100. Biotinylated 
sheep anti-rabbit and anti-mouse immunoglobulins and streptavidin- 
fluorescein were from Amersham International. 
Other Materials 
Transferrin, selenium, putrescine, triiodothyronine, thyroxine, dexa- 
methasone, insulin, cytosine arabinoside, hyaluronidase, laminin, 
poly-L-tysine (molecular weight 300,000), and bovine serum albumin 
(BSA) were obtained from Sigma Chemical Company. Tissue culture 
petri dishes and 24-well plates were from Falcon. Protein A Sepharose 
column was from Pharmacia Biotech. Four-well plates were from Nunc 
Life Technologies. NGF was a gift from Dr. J. Winter; bFGF was from 
R&D Systems. Fetal calf serum was from Advanced Protein Products. 
Dulbecco's modified Eagle's medium (DMEM), minimum essential me- 
dium (MEM), Ham's F12 medium, and trypsin were from GIBCO Labo- 
ratories. Collagenase was obtained from Worthington Biochemical 
Corporation. BrdU was from Boehringer Mannheim. Citifluor was ob- 
tained from City University (London). 
Defined Medium 
Defined medium used in this study was a modification of the medium 
of Bottenstein and Sato (1979). A 1:1 mixture of DMEM and Ham's F12 
was supplemented with (final concentration in parentheses)transferrin 
(100 I~g/ml), progesterone (60 ng/ml), putrescine (16 ilg/ml), insulin 
(5.7 ng/ml, 10 -9 M), IGF1 (100 ng/ml, 13 nM), thyroxine (0.4 t~g/ml), 
selenium (160 ng/ml), triiodothyronine (10.1 ng/ml), dexamethasone 
(38 ng/ml), glucose (7.9 mg/ml), BSA (0.3 mg/ml), penicillin (100 IU/ 
ml), streptomycin (100 IU/ml), and glutamine (2 mM). This medium is 
referred to as defined medium or defined medium without serum. In 
some experiments insulin and/or IGF1 were omitted from the medium; 
this is indicated in the text. 
Cell Cultures 
Cultures of Schwann cells and precursors were prepared essentially 
as described previously (Jessen et al., 1994; Gavrilovic et al., 1995). 
After dissociation and centrifugation, the cells were resuspended in 
defined medium, counted, and plated (at a density of 2000 cells per 
coverslip unless otherwise indicated) in a 10 or 20 ~.1 drop on laminin- 
coated coverslips. After 3 hr, the cultures were topped up with 280 
I~1 of defined medium. Coverslips were coated with poly-L-lysine and 
laminin as described previously (Jessen et al., 1994). 
The survival assay has been described in detail previously (Gavri- 
Iovic et al., 1995; also see Jessen et al., 1994). In brief, 20 hr after 
plating the cells were fixed and immunolabeled with antibody 192 IgG 
against the p75 NQFR or antibody ASCS4 against L1 (see below). The 
number of flattened immunopositive cells at this time point was 
counted in the fluorescence microscope and expressed as a percent- 
age of the number of such cells on sister coverslips 3 hr after plating; 
this figure is referred to as percentage survival. The assay as described 
above is referred to as the 20 hr survival assay. In some experiments, 
survival was examined over longer periods; this is indicated in the 
text. 
The BrdU assay of DNA synthesis was carried out by exposing cells 
to BrdU (20 ~M) for periods of 1.5 hr followed'by double immunola- 
beling using antibodies to L1 (see below) and BrdU. The percentage 
of Ll-positive cells that also had BrdU-positive nuclei was taken to 
indicate the proportion of glial cells that synthesized DNA. 
For identification of Schwann cell precursors, antibodies against L1 
were used in most experiments, although the results were generally 
checked using antibodies against the p75 NaFR, which served as the 
antigenic marker for precursor identification in our earlier experiments 
(Jessen et al., 1994; Gavrilovic et al., 1995). Schwan n cell precursors 
express cell surface L1 immunoreactivity (Jessen et al., 1994). In the 
present study, we carried out double-immunofluorescence xperi- 
ments using ASCS4 antibody and 192 IgG antibody to detect L1 and 
NGFR, respectively, and class-specific fluorochrome-labeled anti- 
mouse second layer antibodies. All the Ll-immunolabeled cells also 
expressed p75 NGFR. On the other hand, p75 N°FR was also detectable 
on a few Ll-negative cells. In cultures maintained in NDF (the condi- 
tions used in nearly all the experiments in the present paper), 3% of 
the p75NGFR-positive cells were L1 negative after 20 h r in vitro, and the 
number of such cells after longer periods in culture was lower (data 
not shown). Some of the L1-negative/p75NG~H-positive cells showed 
neither the flattened morphology nor the group-forming tendency char- 
acteristic of the very great majority of cells in the precursor cultures, 
but tended instead to occur singly on the coverslip; furthermore, prelim- 
inary tests indicated that these cells did not acquire significant $100 
expression with time in culture. It is possible that this small subpopula- 
tion of p75NGFR-positive cells does not belong to the glial lineage. How- 
ever that may be, we have preferred, in the present work, not to make 
our observations on the total p75NGFR-positive population but rather to 
confine them, wherever practicable, to the slightly smaller and more 
homogenous population of cells that express both L1 and p75 ~GFR and 
take part in forming flattened cellular groups. For practical reasons, 
p75 NG~R was nevertheless used to identify precursors in some double- 
labeling experiments; this is indicated in the text. 
For culturing neurons, a pellet of DRG cells was prepared as de- 
scribed elsewhere (Jessen et al., 1994). The cells were then resus- 
pended in 6 ml of DMEM plus 10% fetal calf serum or defined medium, 
and the suspension was transferred to a 90 mm plastic dish coated 
with antibodies against Thy 1.1 in DRG cell suspension. (Thy 1.1 is 
present on both neurons and fibroblasts, but not on glial cells.) After 
2-3 min at 37°C, the dish was washed 4-5 times very quickly with 
DMEM plus 10% fetal calf serum or defined medium. The neurons 
were then streamed off with defined medium containing 50 ng/ml NGF 
and plated in 4-well poly-L-lysine-coated plastic plates at a density of 
100,000-150,000 neurons/well. The volume of culture medium per 
well was 300 Id, and 95% of the cells in the cultures at 20 hr were 
neurons. The medium was changed at 20 hr, and conditioned medium 
was collected at 48 and 72 hr after plating only. 
To coat with anti-Thy 1.1, the dish was first incubated with 6 ml 
of Tris buffer solution (50 mM; pH 9.5) containing rabbit anti-mouse 
immunoglobulin (38 t~g/ml final concentration) for 18 hr at 4°C. It was 
then washed 3 times with phosphate-buffered saline (PBS) and incu- 
bated with a mixture of OX7 antibodies (Mason and Williams, 1980) 
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in the form of culture supernatant (4 ml), MEM-HEPES (2 ml), and 
BSA (400 p.I at 35 mg/ml) for 1-4 hr at room temperature. The dish 
was washed 3 times with PBS and used immediately. 
In replating assays for monitoring precursor maturation, cells from 
nerves at various ages (see Results) were plated at a density of 12,000 
cells per well in 50 p.I of defined medium on laminin-coated, poly-L- 
lysine-coated wells. After 3 hr, the medium was withdrawn and re- 
placed with 300 I~1 of defined medium containing the appropriate con- 
centration of NDF~-2. After 1-4 days in vitro, the cells were rinsed 
once with versene and incubated for 5 min with 300 ~1 of versene plus 
100 p.I of enzyme cocktail at 37°C. The cells were triturated off the 
wells and removed to a centrifuge tube containing defined medium, 
spun at 1000 rpm for 10 rain, and resuspended in defined medium. The 
cells were replated at a density of 2,000 cells in 20 i11 on laminin-coated 
coverslips. After 3 hr, the cultures were topped with defined medium 
for the survival assay, with defined medium containing 3 ng/ml bFGF 
and 5 p.M forskolin for the cell division assay, or fixed for examination 
of $100 expression. 
Construction and Expression of a Secreted Soluble 
ErbB4 Receptor 
To construct a soluble ErbB4 receptor-immunogtobulin chimeric DNA, 
the expression vector CDM7 (Invitrogen) bearing the extracellular por- 
tion of ErbB4 fused in frame to an Fc portion (hinge, CH2, and CH3) 
of a human immunoglobulin y-1 was used. Essentially, the parental 
CDM7 plasmid was digested with BamHI and EcoRI to allow fusion 
of the Fc portion with the extracellular domain of ErbB4 (denoted IgB4). 
The extracellular domain of ErbB4 was amplified by using the polymer- 
ase chain reaction (30 cycles of 1.5 min at 96°C, 2 min at 52°C, and 
3 min at 72°C). The amplifed extracellular domain was purified and 
digested with Bam HI and EcoRI and inserted into the appropriate sites 
in the expression vector. The upstream and downstream oligonucleo- 
tide primers of ErbB4 had the following sequences: 5'-CGCCGGGAAT- 
TCCAAAAAATGAAGCCGGCGAC-3' and 5'-CCCGGGGATCCCTAG- 
CATGTTGTGGTAAAGTGG-3', respectively. The built-in cloning sites 
are underlined. Nucleotide sequencing confirmed the integrity of the 
open reading frames of the chimeric cDNA and also partially verified 
correct sequences. For electroporation of HEK 293 cells, 10 p.g of the 
resulting IgB4 plasmid together with 0.5 I~g of pSV2/neo was mixed 
with 2 x 106 cells in 0.8 ml of DMEM The electroporation was carried 
out with a Bio-Rad gene pulser using voltage and capacitance settings 
of 270 V and 960 I~F, respectively. Individual clones were selected 
with G418 (800 p.g/ml) and maintained in DMEM with 10% fetal calf 
serum. The conditioned media were assayed with a goat anti-human 
antibody to select positive clones that secreted the fusion proteins. 
Media conditioned by a selected cell clone were then purified using 
protein A Sepharose column. Protein concentration was estimated by 
get staining and comparison with 
Neuron 
596 
Marchionni, M. A., Goodearl, A. D. J., Chen, M. S., Bermingham- 
McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sud- 
halter, J., Kobayashi, K., et al, (1993). Glial growth factors are alterna- 
tively spliced erbB2 ligands expressed in the nervous system. Nature 
362, 312-318. 
Mason, D. W., and Williams, A. F. (1980). The kinetics of antibody 
binding to membrane antigens in solution and at the cell surface. Bio- 
chem. J. 187, 1-20. 
Meyer, D., and Birchmeier, C. (1994). Distinct isoforms of neuregulin 
are expressed in mesenchymal and neuronal cells during mouse de- 
velopment. Proc. Natl. Acad. Sci. USA 91, 1064-1068. 
Orr-Urtreger, A., Trakhtenbrot, L., Ben-Levy, R., Wen, D., Rechavi, G., 
Lonai, P., and Yarden, Y. (1993). Neural expression and chromosomal 
mapping of Neu differentiation factor to 8p12-p21. Proc. Natl. Acad. 
Sci. USA 90, 1867-1871. 
Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, 
S. G., Ben-Levy, R., and Yarden, Y. (1992). Isolation of the neulHER-2 
stimulatory ligand: a 44 kd glycoprotein that induces differentiation of 
mammary tumor cells. Cell 69, 205-216. 
Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., and Yarden, Y. 
(1993). Cell-type specific interaction of Neu differentiation factor (NDF/ 
heregutin) with Neu/HER-2 suggests complex ligand-receptor relation- 
ships. EMBO J. 12, 961-971. 
Pinkas-Kramarski, R., Eilam, R., Spiegler, O., Lavi, S., Liu, N., Chang, 
D., Wen, D., Schwartz, M., and Yarden, Y. (1994). Brain neurons and 
glial cells express Neu differentiation factor/heregulin: a survival factor 
for astrocytes. Prec. Natl. Acad. Sci. USA 91, 9387-9391. 
Plowman, G. D., Culouscou, J.-M., Whitney, G. S., Green, J. M., Carl- 
ton, G. W., Foy, L., Neubauer, M. G., and Shoyab, M (1993a). Ligand- 
specJfic activation of HER4/p180 *rbB4, a fourth member of the epidermal 
growth factor receptor family. Proc. Natl. Acad. Sci. USA 90, 1746- 
1750. 
Plowman, G. D., Green, J. M., Culouscou, J.-M., Carlton, G. W., Roth- 
well, V. M., and Buckley, S. (1993b). Heregulin induces tyrosine phos- 
phorylation of HER4/p180 ~b~4. Nature 366, 473-475. 
Raft, M. C., Abney, E., Brockes, J. P., and Hornby-Smith, A. (1978). 
Schwann cell growth factors. Cell 15, 813-822. 
Ratner, N., Bunge, R. P., and Glaser, L. (1985). A neuronal heparan 
sulfate proteoglycan is required for dorsal root ganglion neuron stimu- 
lation of Schwann cell proliferation. J Cell Biol. 101, 744-754. 
Sara, V. R., and Hall, K. (1990). Insulin-like growth factors and their 
binding proteins. J. Am. Physiol. Soc. 70, 591-614. 
Shah, N. M., Marchionni, M. A., Isaacs, I., Stroobant, P., and Ander- 
son, D. J. (1994). Glial growth factor restricts mammalian neural crest 
stem cells to a glial fate. Cell 77, 349-360. 
Sliwkowski, M. X., Schaefer, G., Aktia, R. W., Lofgren, J. A., Fitzpat- 
rick, U. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, 
R. L., and Carraway, K. L. (1994). Coexpression of ErbB-2 and ErbB-3 
protein reconstitutes a high affinity receptor for heregulin, J. Biol. 
Chem. 269, 14661-14665. 
Stewart, H. J. S., Morgan, L., Jessen, K. R., and Mirsky, R. (1993). 
Changes in DNA synthesis rate in the Schwann cell lineage in vivo are 
correlated with the precursor-Schwann cell transition and myelination. 
Eur. J. Neurosci. 5, 1136-1144. 
Sweadner, K. J. (1983). Post-translational modification and evoked 
release of two large surface proteins of sympathetic neurons. J. Neu- 
rosci. 3, 2504-2517. 
Tzahar, E., Levkowitz, G., Karunagaran, D., Yi, L., Peles, E., Lavi, S., 
Chang, D., Liu, N., Yayon, A., Wen, D., and Yarden, Y. (1994). ErbB-3 
and ErbB-4 function as the respective low and high affinity receptors 
of all Neu differentiation factor/heregulin isoforms. J. Biol. Chem. 269, 
25226-25233. 
Vartanian, T., Corfas, G., Li, Y., Fischbach, G. D., and Stefansson, 
K. (1994). A role for the acetylcholine receptor-inducing protein ARIA in 
oligodendrocyte development. Proc. Natl. Acad. Sci. USA 91, 11626- 
11630. 
Wen, D., Petes, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., 
Trail, G., Hu, S., Silbiger, S. M., Ben Levy, R., et al. (1992). Neu 
differentiation factor: a transmembrane glycoprotein containing an 
EGF domain and an immunoglobulin homology unit. Cell 69, 559- 
572. 
Wen, D., Suggs, S. V., Karunagaran, D., Liu, N., Cupples, R. L., Luo, 
Y., Janssen, A. M., Ben-Baruch, N., Trollinger, D. B., Jacobsen, 
V. L., et al. (1994). Structural and functional aspects of the multiplicity 
of Neu differentiation factors. Mol. Cell. Biol. 14, 1909-1919. 
